Phase 1 Depressive Disorder, Major Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant

Washington University School of Medicine60 enrolled1 locationNCT02994433

Recruiting

Phase 1

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Post Traumatic Stress DisorderDepressive Disorder, Major

Yale University50 enrolled1 locationNCT05915013